Nexalin Technology Inc
General ticker "NXL" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $42.1M
Nexalin Technology Inc follows the US Stock Market performance with the rate: 39.2%.
Estimated limits based on current volatility of 8.2%: low 2.50$, high 2.95$
Factors to consider:
- China accounted for 91.4% of revenue in the fiscal year ended 2022-12-31
- US accounted for 8.6% of revenue in the fiscal year ended 2022-12-31
- Current price 309.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.20$, 0.64$]
- 2024-12-30 to 2025-12-30 estimated range: [0.18$, 0.57$]
Short-term NXL quotes
Long-term NXL plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.14MM | $1.32MM | $0.11MM |
| Operating Expenses | $6.16MM | $3.15MM | $5.81MM |
| Operating Income | $-6.02MM | $-1.83MM | $-5.70MM |
| Non-Operating Income | $-0.11MM | $0.09MM | $1.05MM |
| Interest Expense | $0.08MM | $0.06MM | $0.04MM |
| R&D Expense | $0.14MM | $0.51MM | $1.92MM |
| Income(Loss) | $-6.12MM | $-1.74MM | $-4.65MM |
| Other Income(Loss) | $0.00MM | $0.04MM | $0.00MM |
| Profit(Loss) | $-6.12MM | $-1.71MM | $-4.65MM |
| Stockholders Equity | $-1.68MM | $5.48MM | $3.21MM |
| Inventory | $0.03MM | $0.15MM | $0.16MM |
| Assets | $0.75MM | $7.43MM | $3.63MM |
| Operating Cash Flow | $-1.08MM | $-2.22MM | $-3.84MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.11MM |
| Investing Cash Flow | $0.00MM | $-6.79MM | $4.45MM |
| Financing Cash Flow | $1.66MM | $8.51MM | $-0.20MM |
| Earnings Per Share* | $-0.85 | $-0.26 | $-0.63 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.